David Tepper Appaloosa LP
David Tepper, founder of Appaloosa Management, is a billionaire hedge fund manager renowned for his expertise in distressed debt investing and contrarian bets. He is known for high-risk, high-reward strategies that have generated significant returns, such as investing in struggling banks during the 2008 financial crisis. His investment philosophy emphasizes deep value analysis, understanding market psychology, and making high-conviction decisions, often going against prevailing sentiment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NRG Energy
NRG
|
+$170M |
| 2 |
Meta Platforms (Facebook)
META
|
+$157M |
| 3 |
Micron Technology
MU
|
+$131M |
| 4 |
Ally Financial
ALLY
|
+$128M |
| 5 |
Apple
AAPL
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$145M |
| 2 |
PNC Financial Services
PNC
|
+$110M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$72.9M |
| 4 |
WPZ
Williams Partners L.P.
WPZ
|
+$69M |
| 5 |
General Motors
GM
|
+$60.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.03% |
| 2 | Communication Services | 16.31% |
| 3 | Healthcare | 13.13% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Financials | 8.32% |
Similar funds
David Tepper's Q3 2017 Portfolio in Review
As of Q3 2017, David Tepper held 62 positions worth $7.12B, up 5.6% from $6.74B the previous quarter. Its ten largest holdings account for 57% of the portfolio.
David Tepper's Q3 2017 filing shows 4 new, 15 increased, 28 reduced and 14 closed positions. Its largest new stake was Peabody Energy Corporation Series A Convertible Preferred Stock: 301,316 shares worth $18.6M. The largest sale was Allergan plc, an estimated $145M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 15% a quarter earlier, followed by Communication Services and Healthcare.
- David Tepper's largest Q3 2017 buy was Peabody Energy Corporation Series A Convertible Preferred Stock: 301,316 shares worth $18.6M.
- David Tepper added most to NRG Energy in Q3 2017, an estimated $170M increase.
- David Tepper's biggest Q3 2017 reduction was Allergan plc, cutting an estimated $145M.
- David Tepper fully exited iShares Biotechnology ETF in Q3 2017, selling an estimated $72.9M.
- David Tepper's ten largest holdings make up 57% of its $7.12B portfolio in Q3 2017.
- David Tepper opened 4 new positions and closed 14 in Q3 2017.
- David Tepper's portfolio value rose 5.6% quarter-over-quarter to $7.12B.
Based on Appaloosa LP's 13F filing for Q3 2017, filed 14 Nov 2017.